![Sailaja Puttagunta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sailaja Puttagunta
No open positions remaining
Net worth: 311 $ as of 30/03/2026
Profile
Sailaja Puttagunta formerly worked at Durata Therapeutics, Inc., as Vice President-Development & Medical Affairs in 2014, Allergan UC, as Vice President-Medical Affairs from 2015 to 2016, Iterum Therapeutics Plc, as Vice President-Development from 2016 to 2018, BiomX Ltd., as Chief Medical Officer from 2018 to 2019, BiomX, Inc., as Chief Medical Officer from 2019 to 2021, and Iterum Therapeutics Plc, as Chief Medical Officer from 2021 to 2024.
Dr. Puttagunta received her graduate degree from New York University School of Medicine and undergraduate degree from Gandhi Medical College & Hospital.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/11/2025 | 10,369 ( 0.02% ) | 311 $ | 30/03/2026 |
Former positions of Sailaja Puttagunta
| Companies | Position | End |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 30/05/2024 |
| BIOMX INC. | Chief Tech/Sci/R&D Officer | 12/12/2021 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Chief Tech/Sci/R&D Officer | 30/09/2019 |
| ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 30/11/2018 |
| ALLERGAN PLC | Chief Tech/Sci/R&D Officer | 31/12/2015 |
Training of Sailaja Puttagunta
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
34
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gandhi Medical College & Hospital
 Gandhi Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
BiomX, Inc.
 BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
- Stock Market
- Insiders
- Sailaja Puttagunta
